![](/img/cover-not-exists.png)
A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC
Fumoleau, P., Chevallier, B., Kerbrat, P., Krakowski, Y., Misset, J.-L., Maugard-Louboutin, C., Dieras, V., Azli, N., Bougon, N., Riva, A., Roche, H.Volume:
7
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/oxfordjournals.annonc.a010544
Date:
February, 1996
File:
PDF, 648 KB
english, 1996